O
Onalabs
Biotech & Life Sciences · Barcelona, Spain · Founded 2016
Wearable devices for non-invasive biomarker monitoring MoreLess
Onalabs is a medical technology company founded in Barcelona, Spain, in December 2016 by Elisabet del Valle (CEO), Xavier Munoz (CSO), and Jordi Garriga. The founders' backgrounds are in science and patents, which has guided the company's focus on protecting its intellectual property. Del Valle, with a background in biochemistry, was driven by a fascination with life sciences to co-found the company. Onalabs has secured a total of $3.18 million in funding over seven rounds, including grants and seed funding. A notable seed round in October 2023 raised $1.9 million, led by FC Barcelona's Barça Innovation Hub (BIHUB), which became a strategic partner and shareholder.
The company develops non-invasive, wearable medical devices that analyze biomarkers in sweat, effectively turning the skin into a data platform. Its business model includes both direct-to-consumer (B2C) sales and collaborations with distributors (B2B2C). The core technology is based on sensory bioengineering and uses disposable cartridges for sweat collection and analysis, which are connected to a mobile app and cloud platform. Onalabs holds the ISO 13485 certification for medical device quality management and a manufacturing license from the Spanish Agency of Medicines and Medical Devices (AEMPS).
Onalabs has three main products. ONASPORT is a chest strap device for athletes that measures lactate levels, electrolyte loss, dehydration, and heart rate in real-time to optimize training and prevent injuries. It has been tested with sports institutions like CAR Sant Cugat and INEFC-UB and is being further developed with FC Barcelona's athletes. The company launched its first physical retail point for ONASPORT in Andorra in February 2026. The second product, ONAVITAL, is designed for remote monitoring of chronic patients, tracking vital signs such as arterial pressure, oxygen saturation, and skin temperature. A third product, ONADM, is in the laboratory phase and aims to provide non-invasive, continuous glucose monitoring for diabetic patients.
Keywords: non-invasive monitoring, wearable biosensors, sweat analysis, biomarker detection, sports performance, remote health monitoring, chronic disease management, lactate monitoring, digital health, medical devices, sensory bioengineering, FC Barcelona, Barça Innovation Hub, ONASPORT, ONAVITAL, Elisabet del Valle, Xavier Munoz, sports technology, athlete monitoring, personalized medicine, MedTech, health data platform
Talent graph
Onalabs's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Onalabs's cap table
Sourced from Dealroom's funding and investor records.







Global footprint
Where Onalabs has talent and traffic
team presence
Market sentiment
What the market is saying about Onalabs
An AI-synthesized read of the highest-engagement posts about Onalabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Onalabs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.